Skip to Main Content

Paper Details

Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder.
Transl Psychiatry
124
2017
ADD3, BD, BD I, BD II, Bipolar Disorder, XPNPEP1, bipolar disorder, brain-enriched cytoskeleton protein adducin 3, chromosome 10, major depressive disorder, neuropeptide-specific aminopeptidase P, non-coding RNA, patients, polygenic risk alleles, rs10884920, schizoaffective disorder, schizophrenia
Author NameAffiliation
Alexander W CharneyIcahn School of Medicine at Mount Sinai
Eli A StahlIcahn School of Medicine at Mount Sinai
Eli A StahlInstitute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai
Kimberly ChambertStanley Center for Psychiatric Research, Broad Institute of Harvard and MIT
Katherine Gordon-SmithUniversity of Worcester
Phil H LeeStanley Center for Psychiatric Research, Broad Institute of Harvard and MIT
Phil H LeeHarvard Medical School
Phil H LeeCenter for Human Genetic Research, Massachusetts General Hospital
Laura J FochtmannStony Brook University
Elaine K GreenPlymouth University Peninsula Schools of Medicine and Dentistry, Plymouth University
Lena BacklundKarolinska Institutet
Lena BacklundKarolinska Institutet
Sarah E BergenStanley Center for Psychiatric Research, Broad Institute of Harvard and MIT
Sarah E BergenKarolinska Institutet
Martin SchallingKarolinska Institutet
Panos RoussosIcahn School of Medicine at Mount Sinai
Panos RoussosFriedman Brain Institute, Icahn School of Medicine at Mount Sinai
Panos RoussosInstitute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai
James A KnowlesUniversity of Southern California, Keck School of Medicine
James A KnowlesZilkha Neurogenetic Institute, University of Southern California, Keck School of Medicine
Ian Jones
Lisa JonesUniversity of Worcester
Christina M HultmanIcahn School of Medicine at Mount Sinai
Christina M HultmanKarolinska Institutet
Christina M HultmanIcahn School of Medicine at Mount Sinai
Christina M HultmanKarolinska Institutet
Roy H PerlisCenter for Experimental Therapeutics, Massachusetts General Hospital
Roy H PerlisCenter for Experimental Therapeutics, Massachusetts General Hospital
Shaun PurcellIcahn School of Medicine at Mount Sinai
Shaun PurcellFriedman Brain Institute, Icahn School of Medicine at Mount Sinai
Shaun PurcellInstitute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai
Shaun PurcellIcahn School of Medicine at Mount Sinai
Shaun PurcellInstitute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai
Shaun PurcellFriedman Brain Institute, Icahn School of Medicine at Mount Sinai
Steven A McCarrollStanley Center for Psychiatric Research, Broad Institute of Harvard and MIT
Steven A McCarrollHarvard Medical School
Carlos N PatoUniversity of Southern California, Keck School of Medicine
Carlos N PatoZilkha Neurogenetic Institute, University of Southern California, Keck School of Medicine
Michele T PatoUniversity of Southern California, Keck School of Medicine
Michele T PatoZilkha Neurogenetic Institute, University of Southern California, Keck School of Medicine
Nick Craddock
Mikael Land??nKarolinska Institutet
Mikael Land??nInstitute of Neuroscience and Physiology, Sahlgenska Academy at the Gothenburg University
Jordan W SmollerStanley Center for Psychiatric Research, Broad Institute of Harvard and MIT
Jordan W SmollerHarvard Medical School
Jordan W SmollerCenter for Human Genetic Research, Massachusetts General Hospital
Jordan W SmollerCenter for Human Genetic Research, Massachusetts General Hospital
Pamela SklarIcahn School of Medicine at Mount Sinai
Pamela SklarInstitute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai
Pamela SklarFriedman Brain Institute, Icahn School of Medicine at Mount Sinai
  • 1 - 50

Datasets